Autonomous Therapeutic Navigation: Microenvironment-Guided Protein Therapeutics for Infectious Disease and Immune Modulation
A lecture by Dr. Jing Wen, UCLA Department of Microbiology, Immunology, and Molecular Genetics
Join the June 2026 installment of the Division of Oral and Systemic Health Sciences' Seminar Series. All are welcome, and no RSVP is required. One unit of continuing education credit is available for attendees!
The research interest of Dr. Jing Wen – Assistant Adjunct Professor, UCLA Department of Microbiology, Immunology, & Molecular Genetics – has been focused on immunotherapy and gene therapy for treatment of human immunodeficiency virus (HIV) infection, cancer, and central nervous system (CNS) diseases. Particularly, she has developed a delivery platform with effective blood-brain-barrier (BBB) penetration capability. This platform affords effectively delivery of monoclonal antibodies, nerve growth factors, and other therapeutic to the brain, opening a new avenue for treatment of CNS diseases, such as neuron degeneration, primary and metastatic brain tumors, spinal cord injury, and HIV CNS infection.
